Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Handscan optical measurements in early rheumatoid arthritis
NL-OMON49310Phase 4Not yet recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jul 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in rheumatoid arthritis (RA) comparing Methotrexate monotherapy, Methotrexate plus methylprednisolone and Methotrexate plus sarilumab (3 arms). Planned start Jul 2020; status: not yet recruiting.
02
Drugs
methotrexatemethylprednisolonesarilumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON49310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49310.